Abevmy 100 mg (Bevacizumab SOLUTION) 100 MG

ABEVMY 100 MG is a bevacizumab solution for intravenous use, designed for targeted therapy. This biosimilar medication is used to support cancer treatment protocols.

Strength

100 MG

Manufacturer / TM Owner

BIOSIMILAR COLLABORATIONS IRELAND LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ABEVMY 100 MG is primarily used in the treatment of certain types of cancer. It works by targeting specific proteins in the body to help slow the growth and spread of cancer cells. This medication is often used in combination with other cancer treatments.

Side Effects

Common effects of ABEVMY 100 MG may include fatigue, high blood pressure, and changes in appetite. Some individuals may also experience nausea or vomiting. It's important to discuss any persistent or severe effects with a healthcare provider.

Precautions & Warnings

ABEVMY 100 MG should be handled with care and administered by a healthcare professional. It is important to follow all safety guidelines and storage instructions provided. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Avoid Interactions

ABEVMY 100 MG may interact with other medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult with a healthcare professional before starting any new medication.

Frequently Asked Questions

ABEVMY 100 MG is used in the treatment of certain types of cancer, often in combination with other therapies.

ABEVMY 100 MG is administered intravenously by a healthcare professional.

Common effects may include fatigue, high blood pressure, and changes in appetite.

It may interact with other medications, so it's important to consult a healthcare provider before combining treatments.

ABEVMY 100 MG is manufactured by Biosimilar Collaborations Ireland Limited.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.